Proclara Biosciences

Antibodies targeting misfolded proteins in neurodegenerative diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2006 groups4 employees language proclarabio.com

Registered entities

Innovation

7 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 1,410 times.

YearFilings
20141
20151
20162
20174
20185
20193
20202
20212
20223
20231

Investor mix

4 investors on record; lead investors include Merieux Equity Partners.

Investor typeCountShare
Private equity250%
Other / undisclosed250%
Coming soon